The Enterprise Value as of December 2025 (TTM) for Carna Biosciences, Inc. (4572.T) is 3.56B

According to Carna Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.56B. This represents a change of -20.02% compared to the average of 4.45B of the last 4 quarters.

Carna Biosciences, Inc. (4572.T) Historical Enterprise Value (quarterly & annually)

How has 4572.T Enterprise Value performed in the past?

The mean historical Enterprise Value of Carna Biosciences, Inc. over the last ten years is 11.17B. The current 3.56B Enterprise Value has changed 3.09% with respect to the historical average. Over the past ten years (40 quarters), 4572.T's Enterprise Value was at its highest in in the March 2016 quarter at 29.69B. The Enterprise Value was at its lowest in in the December 2024 quarter at 3.65B.

Carna Biosciences, Inc. (4572.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Carna Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Carna Biosciences, Inc. (4572.T) Average Enterprise Value

How has 4572.T Enterprise Value performed in the past?

The current Enterprise Value of Carna Biosciences, Inc. (4572.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Carna Biosciences, Inc. (4572.T) Enterprise Value vs. Peers

How is 4572.T’s Enterprise Value compared to its peers?

Carna Biosciences, Inc.’s Enterprise Value is greater than Ribomic Inc. (1.93B), greater than FunPep Company Limited (1.16B), less than Delta-Fly Pharma, Inc. (5.18B), greater than Kubota Pharmaceutical Holdings Co., Ltd. (1.89B), less than Immuno-Biological Laboratories Co., Ltd. (12.29B), less than Trans Genic Inc. (5.26B), less than D. Western Therapeutics Institute, Inc. (4.03B), greater than Kringle Pharma, Inc. (1.05B), greater than Human Metabolome Technologies, Inc. (2.27B), greater than Soiken Holdings Inc. (1.69B),

Build a custom stock screener for Carna Biosciences, Inc. (4572.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carna Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carna Biosciences, Inc. (4572.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carna Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.